Gaurav Rathi

A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial

Dragoş Vinereanu, Renato D. Lópes, M. Cecilia Bahit et al. · The Lancet · 2017 · 213 citations

Medicine, Cardiology, Pharmacotherapy +13

Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway <scp>Co‐Expression</scp> Patterns: A <scp>Double‐Blind</scp>, Randomized, <scp>Placebo‐Controlled</scp>, Phase 2 Trial

Joan T. Merrill, Joel M. Guthridge, Miles Smith et al. · Arthritis & Rheumatology · 2023 · 63 citations

Life Sciences, Immunology, Pharmacology +17

A prospective, randomized, double‐blind, multicentre, parallel‐group, active controlled study to compare efficacy and safety of biosimilar adalimumab (Exemptia;<scp>ZRC</scp>‐3197) and adalimumab (Humira) in patients with rheumatoid arthritis

Rajendrakumar H. Jani, Rajiv Gupta, Girish Bhatia et al. · International Journal of Rheumatic Diseases · 2015 · 62 citations · Full text

Life Sciences, Clinical Sciences, Pharmacotherapy +14

Evaluation of factors causing delayed graft function in live related donor renal transplantation.

Avinash Sharma, S.L Tolani, Gaurav Rathi et al. · PubMed · 2010 · 22 citations · Full text

Medicine, Nephrology, Surgery +12

OP0012 A Phase 3, Randomized, Double-Blind, Active Comparator Study of the Efficacy and Safety of Bow015, A Biosimilar Infliximab, in Patients with Active Rheumatoid Arthritis on Stable Methotrexate Doses

Jonathan Kay, Arvind Chopra, S Chandrashekara et al. · Annals of the Rheumatic Diseases · 2014 · 16 citations

Medicine, Pharmacology, Pharmacotherapy +13